Every stroke caregiver eventually gets the same email from a well-meaning relative: “Have you seen this brain device?” 🧠 Some of those devices are real, regulated and sitting in rehab clinics. Others are demos, small trials or wellness gadgets with a stroke photo on the box. Telling them apart is the hard part, and nobody hands you a manual.
This guide sorts the options by what is proven. I keep three categories apart on purpose: FDA-authorized rehab devices, stimulation methods that have mixed or negative trial results, and research-stage implants that are not available to you. I am not a clinician, and nothing here replaces your neurologist or therapist. It is a map for the conversation you are about to have with them. Which of these has anyone on your care team already mentioned?
Two devices with an FDA green light for the arm and hand
Both of these target the upper limb after chronic stroke, meaning months or years out, when recovery has usually plateaued. Both need a therapist involved. Only one needs surgery. 🦾
Vivistim: a pulse generator paired with therapy
Vivistim, made by MicroTransponder, is an implanted vagus nerve stimulation system. A pulse generator sits in the chest, a lead wire runs to electrodes on the vagus nerve in the neck, and stimulation is timed to rehab exercises. The FDA approved it on August 27, 2021 for moderate to severe arm and hand weakness after chronic ischemic stroke, as HCPLive reported.
Trial: VNS-REHAB, the randomized study behind the approval, with 108 participants (53 active, 55 control)
Arm function on the Fugl-Meyer scale: 5 points gained with VNS versus 2.4 in controls, a 2.6-point gap
Response at 90 days (6 points or more): 47.2% with VNS versus 23.6% in controls
Catch: it is surgery, so the risk-benefit talk belongs with a neurologist and a surgeon
Read those numbers carefully. Almost half responded, which is better than the control group’s quarter, and it also means more than half did not reach the response threshold. 📊 That is a real effect and not a miracle. I think honest expectations matter more than hype here.
IpsiHand: a brain-controlled glove for home
IpsiHand, from Neurolutions, is a non-invasive brain-computer interface. It has three parts: an EEG-based headset, a tablet, and a powered handpiece worn on the hand and wrist. The headset picks up signals from the unaffected side of the brain that relate to moving the weak hand, and the handpiece opens and closes the hand in response. The FDA granted De Novo authorization with Breakthrough designation on April 26, 2021, for adults doing stroke rehabilitation, and Neurolutions says it is designed for home or clinic use. No implant, no surgery. 🏠
The randomized trial reported by Neurolutions compared 12 weeks of at-home BCI sessions (five per week) with a conventional home exercise program:
62 participants analyzed (37 BCI, 25 control), on average 5.4 years after stroke
Fugl-Meyer gain of 6.0 points versus 1.5 in controls (p = 0.0007)
Clinically meaningful response in 55.5% of BCI users versus 9.6% of controls
The study was stopped early for efficacy, and the source is the manufacturer’s own announcement
Those results sound strong. A trial stopped early and summarized by the company still deserves a second look, so ask your clinician for the peer-reviewed paper. Would you be able to commit to five sessions a week for three months?
What the wider brain-computer interface evidence looks like
IpsiHand is one example of a bigger group of rehab systems that use EEG to detect attempted movement and reward it. Several reviews now pool the randomized trials, including a 2026 meta-analysis of chronic stroke in the Journal of Medical Internet Research. I could not read the full pooled results, so I will not quote a number. Ask your rehab team what the current reviews say about your loved one’s stage of recovery. 🔍
Stage: several BCI rehab systems are still in trials, and only some are cleared devices
Who fits best: the studies I checked focus on arm and hand recovery, so ask about legs and speech separately
What to check: whether a device is authorized for stroke rehabilitation and not just sold as a general EEG gadget
That last point trips people up. Wellness EEG headbands are sold without FDA review as long as they avoid disease claims, a gap that NeurotechMag’s myth-busting piece lays out clearly, and seven questions to ask before buying a brain wearable is a good checklist for the shop counter. 🛒 A device that does not say stroke anywhere in its FDA paperwork is a wellness product, whatever the ad shows. ⚠️
The stimulation approach that did not deliver
Transcranial direct current stimulation (tDCS) passes a weak current through scalp electrodes. It is cheap, painless and heavily marketed, and it looks like the obvious add-on to therapy. The best test so far says otherwise. ⚡
TRANSPORT2, a phase 2 trial in The Lancet Neurology (full text on PubMed Central), enrolled 129 people at 15 US centers. Everyone got 10 sessions of modified constraint-induced movement therapy over two weeks, paired with sham, 2 mA or 4 mA stimulation. The results, as EMJ summarized, were:
Sham: 4.91 Fugl-Meyer points
2 mA: 3.87 points
4 mA: 5.53 points
No significant difference between groups (P = 0.39), and no safety signal between arms 🛡️
So stimulation did not add anything on top of intensive therapy in subacute stroke. The authors call for more work on doses, timing and patient subgroups, which is fair. My take: skip home-built tDCS kits, and treat any stroke-recovery claim for one as unproven. 🚫 The therapy itself, not the current, did the work in that trial. That is the takeaway.
Walking, and what is still years away
Legs get less neurotech attention, but there is a cleared option. Cleared, though, is not the same as available at your local clinic. The ReStore Exo-Suit from Lifeward (formerly ReWalk Robotics) is a soft, powered suit that assists ankle push-off and swing with motors, cables and shoe sensors. Lifeward lists it as FDA and CE cleared for stroke patients with lower limb disability who can walk at least 1.5 meters with minimal to moderate help, and it is used under a trained therapist in rehab settings, not as a home appliance. 🚶 Supervised means a clinic visit, so ask about travel and schedule. 🚗
Stage: cleared for use in supervised rehab
Who: people who already walk with some assistance
Not for: anyone looking for a home device, as far as I can tell from the maker’s page
Then there is the far end of the field. Implanted speech decoders for people who lost speech after ALS or a brainstem stroke are clinical research, not products, as NeurotechMag’s coverage of paralysis and communication explains. If you follow this space closely, NeurotechMag Pro members can track every paper, funding round, and trial connected to developments like these, summarized and searchable. 📈
Questions to bring to the next appointment
Bring this list, and write the answers down. 📝 Ask every question, even the awkward ones. 💬
Is this device FDA-authorized for stroke rehab, or only sold as wellness?
How long since the stroke? Vivistim and IpsiHand data come from chronic stroke, while TRANSPORT2 studied subacute stroke
What outcome will we measure, and by when?
Who supervises, and how many sessions a week can we realistically manage?
What is the risk? Surgery is a very different decision from a headset 🩺
Two devices have randomized-trial evidence and FDA authorization for the arm. One exosuit is cleared for supervised gait rehab. The main stimulation approach tested so far did not beat sham. Which of those questions do you most need answered first? 💡